Published in AIDS Weekly, July 27th, 2009
"The drug target in this assay is the HCV IRES, the activity of which leads to modulation of the renilla...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.